Logo image of UHALB

AMERCO-NON VOTING (UHALB) Stock Fundamental Analysis

NASDAQ:UHALB - Nasdaq - US0235865062 - Common Stock - Currency: USD

53.06  -1.5 (-2.75%)

After market: 53.06 0 (0%)

Fundamental Rating

3

Overall UHALB gets a fundamental rating of 3 out of 10. We evaluated UHALB against 39 industry peers in the Ground Transportation industry. While UHALB is still in line with the averages on profitability rating, there are concerns on its financial health. UHALB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

UHALB had positive earnings in the past year.
In the past year UHALB had a positive cash flow from operations.
UHALB had positive earnings in each of the past 5 years.
In the past 5 years UHALB always reported a positive cash flow from operatings.
UHALB Yearly Net Income VS EBIT VS OCF VS FCFUHALB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 1B -1B

1.2 Ratios

UHALB's Return On Assets of 5.81% is in line compared to the rest of the industry. UHALB outperforms 44.19% of its industry peers.
Looking at the Return On Equity, with a value of 16.70%, UHALB is in line with its industry, outperforming 53.49% of the companies in the same industry.
Industry RankSector Rank
ROA 5.81%
ROE 16.7%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
UHALB Yearly ROA, ROE, ROICUHALB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 5 10 15 20

1.3 Margins

The Profit Margin of UHALB (17.86%) is better than 76.74% of its industry peers.
UHALB's Profit Margin has improved in the last couple of years.
UHALB's Operating Margin of 26.92% is amongst the best of the industry. UHALB outperforms 81.40% of its industry peers.
In the last couple of years the Operating Margin of UHALB has grown nicely.
Industry RankSector Rank
OM 26.92%
PM (TTM) 17.86%
GM N/A
OM growth 3Y20.16%
OM growth 5Y5.75%
PM growth 3Y25.75%
PM growth 5Y10.94%
GM growth 3YN/A
GM growth 5YN/A
UHALB Yearly Profit, Operating, Gross MarginsUHALB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 10 20 30 40

More info and screens

1

2. Health

2.1 Basic Checks

UHALB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for UHALB has been reduced compared to 1 year ago.
The debt/assets ratio for UHALB is higher compared to a year ago.
UHALB Yearly Shares OutstandingUHALB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M
UHALB Yearly Total Debt VS Total AssetsUHALB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 5B 10B 15B

2.2 Solvency

UHALB has a Debt/Equity ratio of 1.00. This is a neutral value indicating UHALB is somewhat dependend on debt financing.
UHALB's Debt to Equity ratio of 1.00 is on the low side compared to the rest of the industry. UHALB is outperformed by 60.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC4.26%
UHALB Yearly LT Debt VS Equity VS FCFUHALB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 2B 4B 6B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.19% over the past year.
Measured over the past years, UHALB shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.98% on average per year.
The Revenue has grown by 9.99% in the past year. This is quite good.
UHALB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.90% yearly.
EPS 1Y (TTM)4.19%
EPS 3Y44.63%
EPS 5Y23.98%
EPS Q2Q%-14.11%
Revenue 1Y (TTM)9.99%
Revenue growth 3Y15.05%
Revenue growth 5Y10.9%
Sales Q2Q%2.32%

3.2 Future

UHALB is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -54.66% yearly.
UHALB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.74% yearly.
EPS Next Y-90.01%
EPS Next 2Y-69.09%
EPS Next 3Y-54.66%
EPS Next 5YN/A
Revenue Next Year3.99%
Revenue Next 2Y7.02%
Revenue Next 3Y6.74%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
UHALB Yearly Revenue VS EstimatesUHALB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
UHALB Yearly EPS VS EstimatesUHALB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

UHALB is valuated cheaply with a Price/Earnings ratio of 0.99.
Compared to the rest of the industry, the Price/Earnings ratio of UHALB indicates a rather cheap valuation: UHALB is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.25. UHALB is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 9.70, which indicates a very decent valuation of UHALB.
Based on the Price/Forward Earnings ratio, UHALB is valued a bit cheaper than the industry average as 79.07% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of UHALB to the average of the S&P500 Index (22.15), we can say UHALB is valued rather cheaply.
Industry RankSector Rank
PE 0.99
Fwd PE 9.7
UHALB Price Earnings VS Forward Price EarningsUHALB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UHALB is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.86
UHALB Per share dataUHALB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

A cheap valuation may be justified as UHALB's earnings are expected to decrease with -54.66% in the coming years.
PEG (NY)N/A
PEG (5Y)0.04
EPS Next 2Y-69.09%
EPS Next 3Y-54.66%

More info and screens

0

5. Dividend

5.1 Amount

UHALB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERCO-NON VOTING

NASDAQ:UHALB (12/16/2022, 8:00:02 PM)

After market: 53.06 0 (0%)

53.06

-1.5 (-2.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)11-09 2022-11-09/amc
Earnings (Next)02-07 2023-02-07
Inst Owners318%
Inst Owner Change0.11%
Ins Owners38.6%
Ins Owner Change0%
Market Cap1.04B
Analysts43.33
Price Target68.71 (29.49%)
Short Float %21.5%
Short Ratio8.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP2.79%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2429.71%
Min EPS beat(2)2429.71%
Max EPS beat(2)2429.71%
EPS beat(4)2
Avg EPS beat(4)865.69%
Min EPS beat(4)-31.77%
Max EPS beat(4)2429.71%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)28.03%
Min Revenue beat(2)28.03%
Max Revenue beat(2)28.03%
Revenue beat(4)1
Avg Revenue beat(4)-6.93%
Min Revenue beat(4)-27.98%
Max Revenue beat(4)28.03%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-90.35%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-90.68%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.39%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.99
Fwd PE 9.7
P/S 0.18
P/FCF N/A
P/OCF 0.64
P/B 0.16
P/tB 0.16
EV/EBITDA 1.86
EPS(TTM)53.75
EY101.3%
EPS(NY)5.47
Fwd EY10.31%
FCF(TTM)-41.67
FCFYN/A
OCF(TTM)82.38
OCFY155.26%
SpS301.07
BVpS321.97
TBVpS329.73
PEG (NY)N/A
PEG (5Y)0.04
Profitability
Industry RankSector Rank
ROA 5.81%
ROE 16.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 26.92%
PM (TTM) 17.86%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y20.16%
OM growth 5Y5.75%
PM growth 3Y25.75%
PM growth 5Y10.94%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA 2.74
Cap/Depr 341.2%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC4.26%
ROIC/WACCN/A
Cap/Depr(3y)290.46%
Cap/Depr(5y)287.78%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.19%
EPS 3Y44.63%
EPS 5Y23.98%
EPS Q2Q%-14.11%
EPS Next Y-90.01%
EPS Next 2Y-69.09%
EPS Next 3Y-54.66%
EPS Next 5YN/A
Revenue 1Y (TTM)9.99%
Revenue growth 3Y15.05%
Revenue growth 5Y10.9%
Sales Q2Q%2.32%
Revenue Next Year3.99%
Revenue Next 2Y7.02%
Revenue Next 3Y6.74%
Revenue Next 5YN/A
EBIT growth 1Y7.07%
EBIT growth 3Y38.25%
EBIT growth 5Y17.28%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1831.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.54%
OCF growth 3Y25.89%
OCF growth 5Y12.93%